Gabapentin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 11.05.2023

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Anticonvulsant and antiepileptic.

Pharmacodynamics (Effect)This section has been translated automatically.

Gabapentin inhibits HVA calcium channels and thus blocks the influx of Ca++ ions into neurons of the CNS.

IndicationThis section has been translated automatically.

Seizures of focal origin; prurigo nodularis and neuropathic pruritus.

Dosage and method of useThis section has been translated automatically.

Adults: Initially start with 100 mg p.o. 3 times/day, increase by 300 mg/day every 1-3 days if needed. Maintenance dose: 900-2400 mg/day, may be increased to 3600 mg/day if needed.

Children & Adolescents > 12 yrs.: Initially start with approximately 50% of the maintenance dose. If needed, increase every 1-3 days up to the maximum dose. Maintenance dose: 30--50 mg/kg/day.

Undesirable effectsThis section has been translated automatically.

Fatigue, ataxia, weakness, somnolence double vision, dizziness nystagmus, headache, tremor.

InteractionsThis section has been translated automatically.

Drug interactions: So far, no clinically relevant interactions are known.

PreparationsThis section has been translated automatically.

Gabax, Neurontin

Note(s)This section has been translated automatically.

Gabapentin is characterised by its rapid dosing capability and minor interactions with other drugs. Compared to other anticonvulsants, it thus has advantages in the treatment of multimorbid epilepsy patients in old age.

A dose-response principle has not been demonstrated. However, 300 mg/day was found to be significantly less effective than 900 or 1800 mg/day.

Authors

Last updated on: 11.05.2023